MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Pfizer offloads Capsugel to KKR for $2.4 billion

Pfizer offloads Capsugel to KKR for $2.4 billion

By

Pfizer, Kohlberg Kravis Roberts

Pfizer Inc. (NYSE:PFE) is selling off its Capsugel unit to private equity firm Kohlberg Kravis Roberts & Co. L.P. (NYSE:KKR) in a $2.38 billion cash deal, the companies said today.

Peapack, N.J.-based Capsugel manufactures hard capsules and drug delivery systems for the pharmaceutical and nutrition industries and generated about $750 million in revenue last year, according to Pfizer. Its divestiture comes on the heals of the company’s $3.6 billion takeover of painkiller maker King Pharmaceuticals Inc. in November.

The world’s largest drug maker expects to fund stock repurchases with the proceeds from the divestiture in 2011 and also said it plans to “identify and invest in other opportunities to maximize its value, including business development.”

Pfizer had already announced plans to buy back $5 billion in shares this year. The company updated its 2011 revenue guidance range from $66.0 billion to $68.0 billion to $65.2 billion to $67.2 billion and pulled back its 2012 revenue targets from $63.0 billion $65.5 billion to $62.2 billion to $64.7 billion.

PFE shares were up about 0.6 percent in mid-day trading and are currently going for about $20.49 apiece.

News of the divestiture overshadowed a “Refusal to File” letter from the FDA for Pfizer’s new drug application for tafamidis, its experimental treatment for Transthyretin Familial Amyloid Polyneuropathy, an incurable neuro-degenerative disease. The FDA found that the application was not sufficiently complete to permit a substantive review, according to the company.

New York-based KKR’s investments in the health-care industry include publicly traded hospital chain HCA Holdings Inc. and orthopedic medical device manufacturer Biomet Inc.

Here’s a roundup of companies announcing mergers, acquisitions and divestitures.

    • Bruker completes of Michrom buyout
      Bruker Corp. (NSDQ:BRKR) announced the closing of its acquisition of Michrom Bioresources Inc., a 20 year old, privately owned company located in Auburn, Calif., after receiving unanimous Michrom shareholder approval. The acquisition is not expected to have a material effect on Bruker’s 2011 financials. All former Michrom employees have been offered employment by Bruker, and Michrom’s founder, Kerry Nugent, joined Bruker as senior vice president.
      Read more

 

    • DJO looks to raise $300 million to fund Dr. Comfort takeover
      DJO Global Inc. plans to offer, in a private offering subject to market and other conditions, $300 million aggregate principal amount of senior unsecured notes due 2018. Obligations under the notes will be guaranteed by all existing and future domestic subsidiaries that guarantee DJO Finance LLC’s (DJOFL) existing senior secured credit facilities, senior unsecured notes due 2014 and senior subordinated notes due 2017. DJOFL intends to use the net proceeds from the offering to fund the estimated $254.6 million purchase price for the acquisition of Rikco International, LLC, D/B/A Dr. Comfort , a provider of therapeutic footwear, pay estimated fees and expenses associated with the acquisition and the related financing and repay an estimated $25.4 million of borrowings currently outstanding on DJOFL’s senior secured revolving credit facility.
      Read more

 

    • OncoSec closes Inovio tumor therapy deal
      OncoSec Medical Inc. (OTC:ONCS) announced that on March 24 it completed its acquisition of certain assets of Inovio Pharmaceuticals, Inc. (NYSE Amex:INO) and entered into a license agreement with Inovio, pursuant to the terms of an asset purchase agreement with Inovio entered into on March 14.
      Read more

 

    • Techne buys Boston Biochem
      Techne Corp. (NSDQ:TECH) announced that as of April 1, its R&D Systems subsidiary has acquired the assets of Boston Biochem Inc., a developer and manufacturer of innovative ubiquitin-related research products.
      Read more

 

    • BAE closes Fairchild Imaging takeover
      BAE Systems Inc. completed the acquisition of the outstanding equity of privately owned Fairchild Imaging Inc. The proposed acquisition was announced January 21. Fairchild makes solid-state electronic imaging components, cameras, and systems for aerospace, industrial, medical, and scientific imaging applications.
      Read more

 

  • Quest completes Athena acquisition
    Quest Diagnostics Inc. (NYSE:DGX) closed its $740 million cash purchase of Athena Diagnostics Inc. from Thermo Fisher Scientific Inc. (NYSE:TMO). The Federal Trade Commission granted Quest an early termination of the premerger review for the deal last week.
    Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • What Laura Mauri learned from a ‘firestorm’ in her first months at Medtronic
    Dr. Laura Mauri faced a monumental moment with former Medtronic CEO Omar Ishrak shortly after she joined the company as VP of global clinical research and analytics. It was late 2018, and Mauri — who’s now an SVP and the chief scientific, medical and regulatory officer at Medtronic (NYSE: MDT) — was in a meeting… […]
  • Senators seek post-market FDA study of pulse oximeters and skin color
    Democratic U.S. senators are prodding the FDA to launch a post-market study of pulse oximeters due to unreliable performance for patients with dark skin. Pulse oximeters estimate blood oxygen levels (SpO2) and pulse rates in patients using infrared light — usually on a fingertip — at home or in clinical settings. Blood oxygenation is one… […]
  • TE Connectivity opens global medical device prototyping center in Ireland
    TE Connectivity (NYSE:TEL) today announced it opened its global Propelus Prototype Center for medical devices in Galway, Ireland. The $5 million rapid prototyping center was built into its existing manufacturing site in Galway and directly connects TE engineers with customers to reduce development time and increase speed to market for lifesaving and life-improving medical devices. Propelus… […]
  • Contract manufacturer Minnetronix Medical launches its first in-house product, MindsEye
    Minnetronix Medical has launched MindsEye, making it the first medical device that the contract developer and manufacturer has conceived and commercialized. St. Paul-based Minnetronix Medical’s MindsEye is the first expandable brain access port on the market. The FDA cleared the device under the 510(k) pathway in August 2020. The minimally invasive device gives neurosurgeons deep… […]
  • What’s next for Jennifer Fried after leaving Explorer Surgical?
    Explorer Surgical co-founder Jennifer Fried has resigned from the company after selling it to Global Healthcare Exchange in October. Fried announced her departure last week on LinkedIn, saying she’s preparing for her next professional chapter. “It’s bittersweet — I’m so proud of everything our team has built and accomplished,” Fried wrote. “The time has flown… […]
  • The 24 best medical device innovations of 2022
    The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products designed to improve the human condition.… […]
  • FDA issues new COVID-19 testing guidance to avoid false negatives
    COVID-19 testing should be repeated following a negative result on any antigen test, the FDA said in a move that could increase demand for diagnostics manufacturers. The latest guidance from the federal health agency is for negative COVID-19 antigen test results regardless of the presence or absence of symptoms. The federal agency said recent studies… […]
  • Confluent Medical expands Costa Rica manufacturing footprint for nitinol, complex catheter production
    Confluent Medical Technologies this week announced the opening of its new addition to its Costa Rica manufacturing facility. The expansion adds 66,000 sq. ft to its large-scale manufacturing center of excellence in Alajuela, Costa Rica to expand Confluent’s capacity for nitinol component processing and complex catheter manufacturing. “Confluent has experienced consistent and strong growth in… […]
  • FDA’s breakthrough medical device designations tally nears 700
    Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted almost 700 designations over the past seven years under a voluntary program for expedited regulatory review of medical devices and combination products that facilitate more effective treatment or diagnosis of serious diseases. According to recent metrics published by FDA, the agency has issued a total of… […]
  • Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing
    Lifecore Biomedical parent company Landec Corp. (Nasdaq:LNDC) plans to take the subsidiary’s name, leadership and headquarters as its own and sell off food businesses to focus on contract development and manufacturing. Santa Maria, California-based Landec said it will rename itself as Lifecore Biomedical “in the near future” and change its Nasdaq ticker to LFCR. Landec… […]
  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]